Cargando…
Impact of CytoSorb® on interleukin-6 in cardiac surgery
OBJECTIVE: Cardiac surgery is known to activate a cascade of inflammatory mediators leading to a systemic inflammatory response. Hemadsorption (HA) devices such as CytoSorb® have been postulated to mitigate an overshooting immune response, which is associated with increased morbidity and mortality,...
Autores principales: | Geisler, Daniela, Arleth, Noemi, Grabenwöger, Johannes, Arnold, Zsuzsanna, Aschacher, Thomas, Winkler, Bernhard, Mach, Markus, Grabenwöger, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498300/ https://www.ncbi.nlm.nih.gov/pubmed/37711559 http://dx.doi.org/10.3389/fcvm.2023.1166093 |
Ejemplares similares
-
CytoSorb-friend or foe!!
por: Pattnaik, Saroj Kumar, et al.
Publicado: (2015) -
Graft preservation confers myocardial protection during coronary artery bypass grafting
por: Szalkiewicz, Philipp, et al.
Publicado: (2022) -
Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial
por: Papazisi, Olga, et al.
Publicado: (2022) -
Efficacy of CytoSorb®: a systematic review and meta-analysis
por: Becker, Sören, et al.
Publicado: (2023) -
Pancreatitis cytosorbents (CytoSorb) inflammatory cytokine removal: A Prospective Study (PACIFIC)
por: Huber, Wolfgang, et al.
Publicado: (2019)